background image


Serving our clients with actionable and insightful research


Senior analysts


Stocks covered


Research reports published in 2022

Our team includes six Ph.D.s who provide unique comprehension of cutting-edge technology to provide market-insights and actionable ideas. In the monthly BioInsights report the team explains leading edge programs in development such as gene editing, artificial intelligence and machine learning, RNA, mRNA, oncology, cell therapies, organ specific diseases and more. The team covers 130 emerging and commercial stage biotechnology companies along with 125 companies in the medical technology, pharmaceutical, IT and services sector. Our well-known bull-bear med-tech debates, along with our monthly dental check-up, diagnostics, animal health and healthcare 2.0 research round out our breadth and depth of coverage.

background image


The Piper Sandler BioInsights research platform provides in-depth analyses across a diverse range of innovative and emerging therapeutic modalities, novel drug targets and disease states, through monthly thematic reports, expert events, catalyst calendars and more.

How can we help?